Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China
· Delayed Price · Currency is CNY 29.94
+1.97 (7.04%)
Apr 29, 2026, 3:00 PM CST
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 11.35 billion as of April 28, 2026. Its market cap has increased by 86.99% in one year.
Market Cap
11.35B
Enterprise Value
11.53B
Revenue
704.16M
Ranking
n/a
PE Ratio
509.78
Stock Price
29.94
Market Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 11.35B, a decrease of -29.82%. That is a compound annual growth rate of -6.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 11.35B | 10.23% |
| Dec 31, 2025 | 10.29B | 139.25% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chongqing Genrix Biopharmaceutical | 11.29B |
| Hualan Biological Vaccine | 11.46B |
| Chengdu Easton Biopharmaceuticals | 11.16B |
| Pacific Shuanglin Bio-pharmacy | 11.67B |
| Vcanbio Cell & Gene Engineering Corp., | 11.92B |
| HitGen | 10.52B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 10.38B |
| Jiangxi Fushine Pharmaceutical | 10.34B |